Fleboflex Luer — Product Overview

The Fleboflex Luer is an advanced IV bag system that combines all the PVC-free, DEHP-free, latex-free polypropylene advantages of the standard Fleboflex container with a needle-free Luer-lock valve for medication access. Manufactured by Grifols and distributed by Bridge, it delivers 0.9% Sodium Chloride Injection, USP (9 g/L NaCl, 308 mOsmol/L, sterile, nonpyrogenic) in a partially-filled, totally collapsible container.

The defining innovation is the Luer-lock injection/extraction port — a needle-free valve that accepts direct syringe or vial-adaptor connections. This eliminates every needle puncture traditionally required during IV bag compounding, removing the risk of accidental needlestick injuries and reducing microbiological contamination from repeated membrane punctures.

Fleboflex Luer containers are available in four partially-filled configurations: 50/100 mL, 100/250 mL, 250/500 mL, and 500/1000 mL. The first number is the fill volume of 0.9% NaCl; the second is the total container capacity. The headroom between fill and capacity is reserved for additive volume — enabling large-volume multi-additive compounding directly inside the bag without overfilling.

Each container meets Class VI U.S. Pharmacopeia (USP) biological safety testing for plastic containers. The solution contacts only polypropylene throughout the fluid path, including the inner membranes of the medication and infusion ports. The polypropylene multilayer film provides full transparency for continuous visual inspection.

Bridge positions Fleboflex Luer as the preferred IV bag for any setting that routinely compounds multi-additive infusions — wellness clinics, med spas, outpatient infusion centers, and in-home IV therapy providers. The needle-free workflow, large additive capacity, and reduced bag entries make it the safest and most efficient option for non-acute compounding.